News

Change - Announcement of Cessation :: Resignation of Group Chief Financial Officer

BackOct 07, 2022
Announcement Title Change - Announcement of Cessation
Date & Time of Broadcast Oct 7, 2022 17:36
Status New
Announcement Sub Title Resignation of Group Chief Financial Officer
Announcement Reference SG221007OTHRISVM
Submitted By (Co./ Ind. Name) Tan Poh Lan
Designation Executive Director and Group CEO
Description (Please provide a detailed description of the event in the box below) Resignation of Group Chief Financial Officer
Additional Details
Name Of Person Choo Boon Yong
Age 53
Is effective date of cessation known? Yes
If yes, please provide the date 28/12/2022
Detailed Reason (s) for cessation To pursue his personal interests
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting? No
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer? No
Any other relevant information to be provided to shareholders of the listed issuer? No
Date of Appointment to current position 01/02/2017
Does the AC have a minimum of 3 members (taking into account this cessation)? Yes
Number of Independent Directors currently resident in Singapore (taking into account this cessation) 2
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months 3
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.) Group Chief Financial Officer
Role and responsibilities Role and responsibilities of a Group Chief Financial Officer
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries NIL
Shareholding interest in the listed issuer and its subsidiaries? Yes
Shareholding Details 328,550
Past (for the last 5 years) 1. Stemlife Therapeutics Sdn. Bhd.
2. Stemlife Properties Sdn. Bhd.
3. Stemlife Biotechnology Sdn. Bhd.
4. SL Diagnostics Sdn. Bhd.
5. Stemlife Pte. Ltd.
Present 1. CS Cell Technologies Pte. Ltd.
2. Cordlife Technologies Pte. Ltd.
3. Shanghai Cordlife Biomedical Research Co. Ltd.
4. Cordlife (Hong Kong) Limited
5. Healthbaby Biotech (Hong Kong) Co., Limited
6. Cordlife Medical Phils., Inc.
7. PT Cordlife Persada
8. Cordlife Sciences (India) Pvt. Ltd.
9. StemLife Berhad
10. Thai Stemlife Co., Ltd.
11. Asia View Holdings Pte. Ltd.
12. Jointek Global Pte. Ltd.
13. Wealthy Step Holdings Limited
14. PowerHF India Private Limited